Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

Todd Neale

June 24, 2019

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Industry News

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

April 09, 2018

News Industry News

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

January 30, 2017

News Industry News

First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft

July 01, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Daily News

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

L.A. McKeown

December 02, 2012

Advertisement

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

Top Endovascular News of 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

BP Reduction With Renal Denervation Still Evident a Decade On

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Renal Denervation a Third Option for Hypertension, European Experts Say

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft

Method Chosen to Estimate Pre-PCI Kidney Function Matters

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content